Search company, investor...
NEOFECT company logo


Founded Year




Date of IPO



NEOFECT (KOSDAQ: 290660) has developed a smart rehabilitation solution to help patients with neurological and musculoskeletal injuries. RAPAEL Rehabilitation Solutions provide rehabilitation training exercises using games. NEOFECT uses data analysis with a proprietary algorithm to provide customized training for each individual patient.

Headquarters Location

Pangyo 2nd Techno Valley Business Growth Center Room 801 42, Changeop-ro, Sujeong-gu

Seongnam, 13449,

South Korea

31 889 8521

Missing: NEOFECT's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NEOFECT's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing NEOFECT

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NEOFECT is included in 2 Expert Collections, including Medical Devices.


Medical Devices

8,633 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items


NEOFECT has filed 43 patents.

The 3 most popular patent topics include:

  • Muscles of the upper limb
  • Physical exercise
  • Virtual reality
patents chart

Application Date

Grant Date


Related Topics




Disability sport classifications, Shoulder, Cytokines, Muscles of the upper limb, Surgery


Application Date


Grant Date



Related Topics

Disability sport classifications, Shoulder, Cytokines, Muscles of the upper limb, Surgery



Latest NEOFECT News

Neofect fails to pay back loan

Oct 11, 2022

Neofect fails to pay back loan 바로가기 기자명 Lee Han-soo 닫기 Neofect, a company specializing in digital rehabilitation, is facing financial troubles as it failed to pay back the principal plus interest. Neofect faces financial troubles as it failed to pay back borrowed money and interest According to the company, it has failed to pay back the principal and interest worth 3.3 billion won ($2.3 million), which is equivalent to 21.5 percent of the company's equity capital (15.3 billion won). Neofect is reviewing the method of repaying the loan by negotiating with creditors and agreeing to pay off the debts by Nov. 30. While the company stressed that it plans to pay back a portion of the loan (2.97 billion won) using its illiquid assets, investors are expressing concerns as this is not the first time the company faced financial troubles. Founded in 2010, Neofect produces medical devices and contents that help patients with nervous systems and musculoskeletal disorders based on artificial intelligence (AI) technology. The company was listed on the Kosdaq market through the "special technology listing" system in 2018. The system alleviates certain listing requirements, such as having to satisfy certain profit requirements, for Kosdaq listing applicants based on their technological power and growth potential. The company has sold products mainly to local hospitals and clinics but it never recorded an operating income so far. At the time of its initial public offering (IPO), Neofect had planned to record 30.2 billion won and 9.8 billion won  in sales and operating profit, respectively, by 2020. However, the business results fell short of its expectations. The company posted only 18.6 billion won in sales, and 14.2 billion won in operating loss, in 2020. In the first half of 2022, its revenue and operating loss recorded6.6 billion won and 1.7 billion won, respectively. As the financial risk burden grew, Neofect succeeded in temporarily relieving its financial risk by conducting a capital increase of 18.6 billion won in 2020. However, investors requested early repayment, which has led to the recent financial crunch. "Since we have more non-current assets than necessary for repayment and can raise additional funds, we will pay the principal and interest without any setbacks by the end of next month," a company official said. "Along with financial improvement activities, we will expand sales and maximize profitability through sales revitalization, and strengthen our sales network mainly in Europe and the U.S., where demand for innovative medical devices is high." Despite the company's explanation, the market reacted negatively toward the news. At the market close on Tuesday, the company's shares ended at 1,100 won, down 10.20 percent from the previous trading day.

NEOFECT Frequently Asked Questions (FAQ)

  • When was NEOFECT founded?

    NEOFECT was founded in 2010.

  • Where is NEOFECT's headquarters?

    NEOFECT's headquarters is located at Pangyo 2nd Techno Valley Business Growth Center Room 801, Seongnam.

  • What is NEOFECT's latest funding round?

    NEOFECT's latest funding round is IPO.

  • Who are NEOFECT's competitors?

    Competitors of NEOFECT include Emovo Care and 1 more.

Compare NEOFECT to Competitors

Flint Rehabilitation Devices

Flint Rehabilitation Devices develops effective, engaging rehabilitation devices that empower people to increase mobility and regain a positive outlook on life during rehabilitation.

Tyromotion Logo

Tyromotion develops and sells integrated solutions for the rehabilitation primarily of stroke patients based on modern robotics and sensor technologies. Smart networking of individual devices allows physicians and therapists to provide their patients wwith intensive treatment. The company's portfolio includes a robot-assisted and computer-assisted device for finger and hand therapy (Amadeo), an arm and shoulder rehabilitation device (Diego).

KineQuantum Logo

KineQuantum aims to transform physical therapy through full body exercises through a virtual reality solution for evaluation and rehabilitation.

Emovo Care Logo
Emovo Care

Emovo Care is a Swiss robotic startup developing accessible assistive devices to bring movement home for people with motor impairments. In order to achieve a high level of dignity and self-support, its devices are carefully designed to provide active movement at home while ensuring independent use. Its first product is a portable orthosis that actively opens and closes the hand for people with limited hand function.

Ubique Tech Logo
Ubique Tech

Ubique Tech has developed HabilUp, a technological tool allowing children and adults with a motor handicap to do their motor rehabilitation at home or with their therapist while having fun.

Bioservo Technologies

Bioservo Technologies (NASDAQ Stockholm: BIOS) is a Swedish company developing muscle strengthening devices based on its patented robotic SEM technology. Its lead product, the SEM Glove, strengthens the users' grip and either compensates where power is lacking or adds extra force and endurance. Bioservo Technologies was founded in 2006 as a result of a collaboration between the Karolinska University hospital and the Royal Institute of Technology.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.